OPKO Health Inc
NASDAQ:OPK
OPKO Health Inc
Revenue
OPKO Health Inc
Revenue Peer Comparison
Competitive Revenue Analysis
Latest Figures & CAGR of Competitors
Company | Revenue | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
OPKO Health Inc
NASDAQ:OPK
|
Revenue
$863.5m
|
CAGR 3-Years
-16%
|
CAGR 5-Years
-3%
|
CAGR 10-Years
25%
|
|
Abbvie Inc
NYSE:ABBV
|
Revenue
$54.3B
|
CAGR 3-Years
6%
|
CAGR 5-Years
11%
|
CAGR 10-Years
11%
|
|
Gilead Sciences Inc
NASDAQ:GILD
|
Revenue
$27.5B
|
CAGR 3-Years
2%
|
CAGR 5-Years
4%
|
CAGR 10-Years
7%
|
|
Amgen Inc
NASDAQ:AMGN
|
Revenue
$28.2B
|
CAGR 3-Years
4%
|
CAGR 5-Years
3%
|
CAGR 10-Years
4%
|
|
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
|
Revenue
$9.9B
|
CAGR 3-Years
17%
|
CAGR 5-Years
26%
|
CAGR 10-Years
23%
|
|
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
|
Revenue
$13.1B
|
CAGR 3-Years
16%
|
CAGR 5-Years
14%
|
CAGR 10-Years
20%
|
OPKO Health Inc
Revenue Breakdown
Breakdown by Geography
OPKO Health Inc
Total Revenue:
863.5m
USD
|
United States:
597.8m
USD
|
Ireland:
141.5m
USD
|
Chile:
68.5m
USD
|
Spain:
23.5m
USD
|
Mexico:
20.2m
USD
|
Israel:
9.7m
USD
|
Other Countries:
2.2m
USD
|
Breakdown by Segments
OPKO Health Inc
Total Revenue:
863.5m
USD
|
Service:
515.3m
USD
|
Transfer Of Intellectual Property And Other:
180.7m
USD
|
Product:
167.6m
USD
|
Rayaldee:
67.5m
USD
|
See Also
What is OPKO Health Inc's Revenue?
Revenue
863.5m
USD
Based on the financial report for Dec 31, 2023, OPKO Health Inc's Revenue amounts to 863.5m USD.
What is OPKO Health Inc's Revenue growth rate?
Revenue CAGR 10Y
25%
Over the last year, the Revenue growth was -14%. The average annual Revenue growth rates for OPKO Health Inc have been -16% over the past three years , -3% over the past five years , and 25% over the past ten years .